Loading...
INDEX: NASDAQ
SYMBOL: ARRY
NAME: Array Biopharma Inc
UPVOTES: 73
DOWNVOTES: 70


Description

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's programs include approximately three cancer drugs, binimetinib, encorafenib and selumetinib (partnered with AstraZeneca, PLC). Its binimetinib and encorafenib are in Phase III trials in advanced cancer patients, including the COLUMBUS trial studying encorafenib in combination with binimetinib in patients with BRAF-mutant melanoma and has initiated BEACON CRC trial to study encorafenib in combination with binimetinib and cetuximab in patients with BRAF V600E-mutant colorectal cancer (BRAFm CRC). Its selumetinib is a mitogen-activated protein kinase (MEK) inhibitor for cancer, which is in Phase III trial. Its advanced clinical-stage drugs include Filanesib, ARRY-797, ASC08/Danoprevir, Ipatasertib/GDC-0068, Motolimod/VTX-2337, LOXO-101, ONT-380/ARRY-380, GDC-0575, GDC-0994 and ARRY-382.

Read Full Descript at Reuters

ARRY Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
ACB30
ARCB20
AUMN10
AMER21
ALQA10
ADMS10
APAFF01
AREX01
AIM01
AET01
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661
Stock SymbolUp VotesDown VotesVote
ALIM52
AGNC63
ACB52
ARCB63
TKSTF31
AMDA42
AXS53
ATTBF42
AMER53
ACAD42
Stock SymbolUp VotesDown VotesVote
SDVI189
AGNC126
ARCB1410
AAPL128
ALIM85
ACAD85
A96
QSEP63
AXS108
IPG31
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661

Last 10 Stocks Voted On

Stock SymbolActionVote
AMERDOWNVOTE
AMERUPVOTE
ACETDOWNVOTE
AGMDOWNVOTE
AETDOWNVOTE
ARCBUPVOTE
ALQAUPVOTE
ARCBUPVOTE
ACBUPVOTE
MSRTDOWNVOTE